Everest Bio Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 14-12-2024
- Paid Up Capital ₹ 1.16 Cr
as on 14-12-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Ebitda
- Net Worth
- Total Assets 0.07%
(FY 2022)
About Everest Bio Sciences
The Corporate was formerly known as Ind-Barath Biosciences Limited. The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.16 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jyothula Ajay, Harika Devavarapu, Narayana Yejna, and One other member serve as directors at the Company.
- CIN/LLPIN
U15510TG2005PLC047161
- Company No.
047161
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Godavari, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Everest Bio Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyothula Ajay  | Director | 20-Jan-2014 | Current |
| Harika Devavarapu | Additional Director | 01-Sep-2018 | Current |
| Narayana Yejna | Director | 23-Nov-2010 | Current |
| Suvarchala Akella | Director | 16-May-2013 | Current |
Financial Performance and Corporate Structure Insights of Everest Bio Sciences.
Everest Bio Sciences Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Everest Bio Sciences?
In 2018, Everest Bio Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Krishna Godavari Lng Terminal Private LimitedActive 11 years 6 monthsJyothula Ajay is a mutual person
- Udbhav Projects Private LimitedActive 27 years 8 months
Jyothula Ajay and Harika Devavarapu are mutual person
- Vaivathsa Logistic Services Private LimitedActive 12 years 3 months
Jyothula Ajay is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Everest Bio Sciences?
Unlock and access historical data on people associated with Everest Bio Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Everest Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Everest Bio Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
